On 27 - 29 January 2021, the 5th RESOLUTE Consortium Meeting took place virtually. RESOLUTE is a public-private partnership, funded with a grant from the Innovative Medicines Initiative (IMI) and coordinated by CeMM and Pfizer, with 13 partners from academia and industry. Its mission is to increase the study of solute carriers for medical research and potential drug development, and it strives to become a reference hub for SLC research and open knowledge worldwide.

This year again virtually, more than 60 RESOLUTE partners joined the online event entitled “Abbey Road Studios” with a focus on different music genres. On the first day, featuring classical and jazz music, participants received the latest updates on reagent generation and deorphanisation technologies. They also joined several focus groups to discuss promising data sets in more detail.

The second day was dedicated to rock, hip-hop and electronic music. Scientists reported the status on transport assays, protein purification and high-affinity binders, in-depth proteomics studies, data management and homology modelling strategies. On this day, the first RESOLUTE training session also took place. Junior investigators had the chance to learn more about project planning from senior investigators in academia, CeMM Scientific Director Giulio Superti-Furga, and Aled Edwards (Structural Genomics Consortium), and from the pharmaceutical industry by Anke Mueller-Fahrnow (Nuvisan) and David Hepworth (Pfizer).

On the last day, the focus groups turned into music bands and played at the RESOLUTE virtual festival. The bands presented the results of their discussions and suggested follow-up strategies. The event ended in team-building activities performed in virtual breakout roms.

We would like to thank all participants and RESOLUTE SAB members for their enthusiasm and fruitful discussions!

Find out more about RESOLUTE: https://re-solute.eu